Method Sign up free

Borrower record · Q2 2026

DNAnexus

As filed by 3 BDCs · period end 30 June 2026Filers label it: Life Sciences Tools & Services (3)1 name variant under review

Three lenders report $15.2m of DNAnexus at Q2 2026, marked at par. First-Lien Senior Secured on all six positions whose seniority a filer disclosed.

Filed fair value
$15.2m
6 funded positions
Reporting lenders
3
across 6 filed positions
Aggregate mark
99.9c
cost filed on all 6 positions
Median spread
525bp
over SOFR, 6 tranches
Maturities to
2029
earliest December 2029
Periods on record
5
first filed Q2 2025

How this total is counted

Pricing as filed

6 floating tranches · SOFR

525bp on all 6 floating tranches — every filer reports the same spread.

6 tranches carry an index floor of 3%.

Capital structure

First-Lien Senior Secured, on all 6 positions whose seniority a filer disclosed.

Rate structure

Floating, on all 6 positions whose interest type a filer disclosed.

Maturity profile

all 6 funded positions dated
2029
$15.2m

3.5 years to maturity, weighted by fair value across the 6 dated positions.

Credit flags

No lender reports this borrower on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Who holds it, and where they mark it.

3 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.

LenderPositionsFair valueMarkSpreadMaturityAccrual

Every filing behind this page

3 filers · Q2 2026
FilerCIKFormPeriodFiledAccession
BlackRock Direct Lending Corp.000183454310-Q2026-06-302026-08-060001193125-26-337958
BlackRock Private Credit Fund (BPCF)000190264910-Q2026-06-302026-08-060001193125-26-338073
BlackRock TCP Capital Corp. (TCPC)000137075510-Q2026-06-302026-08-060001193125-26-336794

Related borrowers

Same lenders